Status:

UNKNOWN

Evaluating Collagen Cross-Linking (CCL) Treatment in Norway

Lead Sponsor:

Ullevaal University Hospital

Conditions:

Keratoconus

Eligibility:

All Genders

20-45 years

Phase:

PHASE2

PHASE3

Brief Summary

The purpose of this study is to assess safety, efficacy and stability of riboflavin-UV induced cross-linking of corneal collagen in reducing the progression of keratecatasia and in improving visual ac...

Detailed Description

The technique of corneal collagen cross-linking consists of photopolymerization of stromal fibers by combined action of a photosensitizing substance, riboflavin and ultraviolet type A rays (UVA) from ...

Eligibility Criteria

Inclusion

  • Age from 20 to 45 years
  • Progressive keratectasia (primary or secondary) in an advanced stage
  • Decreased best corrected visual acuity bellow 20/40, which cannot be further improved by use of soft contact lenses
  • Rigid contact lenses are either not tolerated or do not improve visual acuity
  • No previous eye surgery (except for laser refractive surgery)
  • All patients must provide written informed consent to become a study subject
  • Subjects able to return for scheduled follow-up examinations according to this protocol

Exclusion

  • Corneal thickness \< 400 µm at thinnest position
  • Keratometric - readings above 60 diopters
  • Other active ocular disease than keratectasia
  • Herpes keratitis
  • Previous ocular surgery (other than laser refractive surgery)
  • Patients who were immunocompromised, pregnant or who had atopic syndrome, connective tissue or autoimmune disease
  • Patients with known sensitivity to study medication
  • Subjects with intraocular pressure \> 23 mmHg by Goldmann applanation tonometry, a history of glaucoma, or glaucoma suspects
  • Subjects who intent to participate in other ophthalmic clinical trails during this clinical investigation

Key Trial Info

Start Date :

February 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

January 1 2010

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT00435799

Start Date

February 1 2007

End Date

January 1 2010

Last Update

June 10 2008

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Eye dpt, Ullevål University Hospital

Oslo, Oslo County, Norway, N-0407

2

Eye dpt, University Hospital North Norway

Tromsø, Tromsø, Norway, No-9037